Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Diabetes

Remission of diabetes, desirable, but not essential

On World Diabetes Day, November 14, we must rededicate ourselves to achieving the dream of a diabetes complications-free India

The Hindu

ICMR-NIN scientists find alarming obesity levels in Telangana and Andhra Pradesh

ICMR-NIN study finds alarming obesity rates in Hyderabad & Telugu States; 47.7% urban adults in Telangana & 46.7% rural adults in AP obese. Over 11% urban & 6% rural adults suffer from hypertension; 5% in both regions have diabetes. Adults aged 40-59 & those engaged in clerical/skilled/semi-skilled occupations have higher…

The Hindu

Woman dies after taking Ozempic to lose weight for daughter’s wedding

Trish Webster lost 16 kilograms but the consequences were allegedly lethal

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

People should adopt ‘old-fashioned’ ways of staying healthy – Sir Chris Whitty

Making it easy and attractive for people to exercise is one of the most effective ways of maintaining independence, the Chief Medical Officer said.

The Independent UK

Shortage of medicines hits beneficiaries of Mittayi project for Type 1 diabetic children

Beema & Hiba, two home-makers, are struggling to provide insulin, needles & glucometer strips for their children with Type 1 diabetes. Mittayi, a project implemented by the State govt, provides medicines & care, but has been facing shortages for two weeks. KSSM has clarified that funds for medicines have been…

The Hindu

Paying attention to the resolute link between diabetes and the liver

Diabetes is linked to liver health: 101M Indians have diabetes, 136M prediabetes. Uncontrolled diabetes can lead to fatty liver, hepatic insulin resistance, and hepatic glucose production. This can lead to NASH, cirrhosis, and HCC. Lifestyle changes, calorie restriction, and medicines can help reduce fatty liver and reverse liver changes. Annual…

The Hindu

FDA approves new weight loss drug

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

The Guardian - UK

FDA approves Zepbound, a new obesity drug that will take on Wegovy

Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.

WEKU

Diabetes drug authorised for weight management and loss – MHRA

Obese and overweight adults could have access to Tirzepatide – also known as Mounjaro – if it receives further approval.

The Independent UK

FDA approves new version of diabetes drug Mounjaro for weight loss

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

The Independent UK

Woman dies after taking Ozempic to lose weight for daughter’s wedding

Trish Webster lost 16 kilograms but the consequences were allegedly lethal

The Independent UK

More than 150,000 people with type 1 diabetes to be offered artificial pancreas

Health experts say technology could be 'life-changing' for diabetes patients

Evening Standard

Major diabetes breakthrough as 150,000 people to be offered artificial pancreas

Technology will be ‘game changer’ for people with type 1 diabetes, top health official says

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Drugs aren't required to be tested in people who are obese. Here's why that's a problem

More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies

The Guardian - UK

NHS to offer 150,000 people with type 1 diabetes an artificial pancreas

Move to make more than half of those living with condition in England and Wales eligible for device hailed as gamechanger

The Independent UK

Patients more likely to lose weight if GPs frame options as ‘good news’ – study

People were less likely to sign up to weight-loss programmes when doctors talked about obesity in a negative way, researchers found.

Salon

Salt's impact on T2 diabetes

Sugar is most often associated with T2 diabetes . . . but could salt be just as much of a cause?

Get all your
news in one place.

100’s of premium titles.
One news app.

Newsroom.co.nz

How a 'Rule of Two' could remove our barrier to better drug access

We need to address the unnecessary and wasteful Medsafe approval for tried and tested drugs by much bigger regulatory authorities abroad, argues Dr Eric Crampton

Newcastle Herald

Ozempic's rebranded weight-loss drug should be available next year

'This is real and these medications are here to stay.'

The Independent UK

Nurse accused of killing 17 patients handed new charges

Prosecutors say Heather Pressdee, 41, has admitted to attempting to kill 19 patients

The Guardian - AU

Ozempic overdoses: data reveals Australians sent to emergency after misuse of diabetes drug

Exclusive: NSW poisons information centre received more than 120 calls related to the diabetes drug in a year, 83% of them about medication errors

The Independent UK

Insulin less temperature-sensitive than previously thought, study suggests

The findings could affect millions of people living in low and middle-income countries, particularly those in rural areas.

The Hindu

Low on salt: turning the spotlight on kidney organ donors

Kidney donors must be fully evaluated before donation. Age, blood group, and health are all factors. Minor ailments may not be a contraindication. Evaluation should favour donor. Follow-up is essential post-donation. Diet, exercise, and avoidance of drugs toxic to kidneys are key. Salt intake should be monitored as it can…

The Guardian - UK

Sales soar at Danish firm behind weight-loss drug semaglutide

Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company

1 … 39 40 41 42

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Oxford

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.